{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:58Z","timestamp":1765609258614},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.neuropharm.2004.03.013","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T17:35:56Z","timestamp":1085852156000},"page":"295-303","source":"Crossref","is-referenced-by-count":28,"title":["H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway"],"prefix":"10.1016","volume":"47","author":[{"given":"Nicoletta","family":"Galeotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Malmberg-Aiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Schunack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.03.013_BIB1","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1073\/pnas.96.14.7739","article-title":"Distinct neurochemical features of acute and persistent pain","volume":"96","author":"Basbaum","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB2","first-page":"756","article-title":"Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils","volume":"255","author":"Bleasdale","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01972339","article-title":"Analgesic effect of histamine induced by intracerebral injection into mice","volume":"15","author":"Chung","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB5","first-page":"1330","article-title":"Involvement of calcium and L-type channels in nicotine-induced antinociception","volume":"266","author":"Damaj","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/356350a0","article-title":"Quantal calcium release by purified reconstituted inositol 1,4,5-trisphosphate receptors","volume":"35","author":"Ferris","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.npp.1300111","article-title":"The phospholipase C-IP3 pathway is involved in muscarinic antinociception","volume":"28","author":"Galeotti","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1073\/pnas.88.2.429","article-title":"Molecular cloning of a gene encoding the histamine H2 receptor","volume":"88","author":"Ganz","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/273547a0","article-title":"Opiate-like and abstinence-like effects of intracerebral histamine administration in rats","volume":"273","author":"Glick","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(97)00277-3","article-title":"Using c-fos as a neural marker of pain","volume":"45","author":"Harris","year":"1998","journal-title":"Brain Research Bullettin"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)91544-3","article-title":"Chelerythrine is a potent and specific inhibitor of protein kinase C","volume":"172","author":"Herbert","year":"1990","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB13","first-page":"253","article-title":"International Union of Pharmacology. XIII. Classification of histamine receptors","volume":"49","author":"Hill","year":"1997","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0301-0082(88)90032-9","article-title":"Cellular localization and possible functions for brain histamine: recent progress","volume":"30","author":"Hough","year":"1988","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s002100000326","article-title":"The interaction of U-73122 with the histamine H1 receptor: implications for the use of U-73122 in defining H1 receptor-coupled signaling pathway","volume":"362","author":"Hughes","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.1997.tb48449.x","article-title":"Low molecular weight heparin a neuroprotectant?","volume":"825","author":"Jonas","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1517\/13543784.10.9.1653","article-title":"Therapeutic potential of PKC inhibitors in painful diabetic neuropathy","volume":"9","author":"Kamei","year":"2001","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/bj2670781","article-title":"Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices","volume":"267","author":"Kennedy","year":"1990","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0306-3623(95)02021-7","article-title":"Regulation of [Ca2+]i rise activated by doxepin-sensitive H1-histamine receptors in Jurkat cells, cloned human T lymphocytes","volume":"27","author":"Kitamura","year":"1996","journal-title":"General Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/en.134.1.482","article-title":"Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons","volume":"134","author":"Kjaer","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0006-291X(89)90028-4","article-title":"Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C","volume":"159","author":"Kobayashi","year":"1989","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002826-199708000-00001","article-title":"Irreversible lithium neurotoxicity: an overview","volume":"20","author":"Kores","year":"1997","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1021\/jm00008a007","article-title":"Synthesis and histamine H1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues","volume":"38","author":"Leschke","year":"1995","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0165-6147(00)01691-6","article-title":"Histamine receptors are finally \u201ccoming out\u201d","volume":"22","author":"Leurs","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(74)90198-8","article-title":"Pharmacological evaluation of a new Ca++ antagonist, 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studied in smooth muscle","volume":"27","author":"Malagodi","year":"1974","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0079-6123(00)29005-5","article-title":"Protein kinase subtypes involved in injury-induced nociception","volume":"129","author":"Malmberg","year":"2000","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1476-5381.1994.tb14883.x","article-title":"Role of histamine in rodent antinociception","volume":"111","author":"Malmberg-Aiello","year":"1994","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/PL00004954","article-title":"Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301U, in rodent antinociception","volume":"355","author":"Malmberg-Aiello","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0024-3205(98)00295-1","article-title":"Evidence for hypernociception induction following histamine H1 receptor activation in rodents","volume":"63","author":"Malmberg-Aiello","year":"1998","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1124\/mol.59.5.1012","article-title":"Role of protein kinase Calpha in signaling from the histamine H1 receptor to the nucleus","volume":"59","author":"Megson","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB31","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1002\/j.1460-2075.1990.tb07609.x","article-title":"The ligand binding sites and transduction mechanism in the inositol-1,4,5-triphosphate receptor","volume":"9","author":"Mignery","year":"1990","journal-title":"EMBO Journal"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(00)00202-5","article-title":"Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord","volume":"99","author":"Narita","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.1411571","article-title":"Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C","volume":"258","author":"Nishizuka","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB34","first-page":"497","article-title":"Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure","volume":"192","author":"O\u2019Callaghan","year":"1975","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB35","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB36","first-page":"780","article-title":"Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice","volume":"286","author":"Ohsawa","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB37","first-page":"L365","article-title":"Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression","volume":"259","author":"Panettieri","year":"1990","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annual Reviews of Pharmacology and Toxicology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1994.2656","article-title":"Neomycin inhibition of hormone-stimulated smooth muscle contractions in myometrial tissue","volume":"205","author":"Phillippe","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0024-3205(85)90252-8","article-title":"Analgesic effects of antihistaminics","volume":"36","author":"Rumore","year":"1985","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0304-3959(86)90004-7","article-title":"Clinical efficacy of antihistaminics as analgesics","volume":"25","author":"Rumore","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0021-9150(94)90067-1","article-title":"Histamine as an activator of cell growth and extracellular matrix reconstruction for human vascular smooth muscle cells","volume":"110","author":"Satoh","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(92)90242-V","article-title":"The protein kinase C activators, phorbol 12-myrystate,13-acetate and phorbol 12,13-dibutyrate, are convulsant in the pico-nanomolar range in mice","volume":"213","author":"Smith","year":"1992","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB44","first-page":"688","article-title":"Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness","volume":"253","author":"Smith","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(85)90086-3","article-title":"Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice","volume":"24","author":"Sun","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-6147(98)01184-5","article-title":"A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases","volume":"19","author":"Treiman","year":"1998","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB47","first-page":"108","article-title":"In vivo signal transduction of nociceptive response by kyotorphin (Tyrosine\u2013Arginine) through G\u03b1i- and inositol trisphosphate-mediated Ca2+ influx","volume":"57","author":"Ueda","year":"2002","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(85)90076-0","article-title":"A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen","volume":"24","author":"Vaught","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB52","doi-asserted-by":"crossref","first-page":"13900","DOI":"10.1016\/S0021-9258(17)44003-8","article-title":"Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization","volume":"258","author":"Wakdo","year":"1983","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB49","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1073\/pnas.88.24.11515","article-title":"Expression cloning of acDNA encoding the bovine histamine H1 receptor","volume":"88","author":"Yamashita","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB53","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0021-9258(19)49643-9","article-title":"U73122 Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells","volume":"267","author":"Yule","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2004.03.013_BIB50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","article-title":"Pathobiology of neuropathic pain","volume":"429","author":"Zimmermann","year":"2001","journal-title":"European Journal of Pharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T17:13:44Z","timestamp":1624382024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390804000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0028390804000875"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.03.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}